C-MER Medical Holdings repurchases shares on exchange for HK$322,000
C-MER Medical Holdings Limited submitted its Next Day Disclosure Return on October 8, 2025, detailing a repurchase of its ordinary shares. The company repurchased 160,000 shares on the Exchange on October 8, 2025, at prices ranging from HK$2.00 to HK$2.02, totaling an aggregate price paid of HK$322,000. These repurchased shares are being held as treasury shares.
Following this transaction, the company's issued shares (excluding treasury shares) decreased by 160,000 to 1,244,472,870, representing a 0.0129% change from the opening balance. The number of treasury shares increased to 11,088,000, while the total number of issued shares remained at 1,255,560,870. The repurchase mandate, authorizing the company to buy back shares, was granted on May 19, 2025, covering 125,556,087 shares, of which 160,000 shares have now been repurchased.
The report also lists numerous other share repurchases made for cancellation but not yet cancelled, occurring between July 12, 2024, and May 15, 2025. These range from 38,000 to 1,000,000 shares per event, with prices varying. The company has confirmed that the repurchases comply with Main Board Rules and that no material changes to the Explanatory Statement dated April 23, 2025, have occurred.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when C-MER Eye Care Holdings publishes news
Free account required • Unsubscribe anytime